23 November 2017
News and Views
Links and Services
The latest issue of Alimentary Pharmacology & Therapeutics explores infliximab safety profile and long-term applicability in inflammatory bowel disease.
Most available data on infliximab therapy come from large, short-term, pivotal randomized control
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors